Silverman K C, Cascales C, Genilloud O, Sigmund J M, Gartner S E, Koch G E, Gagliardi M M, Heimbuch B K, Nallin-Omstead M, Sanchez M
Merck and Company, Rahway, NJ 07065, USA.
Appl Microbiol Biotechnol. 1995 Aug-Sep;43(4):610-6. doi: 10.1007/BF00164762.
Actinoplanic acids A and B are macrocyclic polycarboxylic acids that are potent reversible inhibitors of farnesyl-protein transferase. Actinoplanic acids A and B were isolated from Actinoplanes sp. MA 7066 while actinoplanic acid B was isolated from both MA 7066 and Streptomyces sp. MA 7099. Actinoplanic acids A and B are competitive with respect to farnesyl diphosphate and are selective inhibitors of farnesyl-protein transferase because they do not inhibit geranylgeranyl-protein transferase type 1 or squalene synthase. MA 7066 is believed to be a novel species of actinomycetes while MA 7099 is believed to be a novel strain of Streptomyces violaceusniger on the basis of morphological, biochemical and chemotaxonomic characteristics as well as its production of actinoplanic acids.
放线菌酸A和B是大环多羧酸,是法尼基蛋白转移酶的强效可逆抑制剂。放线菌酸A和B是从游动放线菌属菌株MA 7066中分离得到的,而放线菌酸B则是从MA 7066和链霉菌属菌株MA 7099中均分离得到的。放线菌酸A和B对法尼基二磷酸具有竞争性,并且是法尼基蛋白转移酶的选择性抑制剂,因为它们不抑制1型香叶基香叶基蛋白转移酶或鲨烯合酶。基于形态学、生化和化学分类学特征以及其放线菌酸的产生,MA 7066被认为是一种新型放线菌,而MA 7099被认为是一种新型的紫黑链霉菌菌株。